Multiple myeloma is a type of cancer that develops in plasma cells, which are part of the immune system. These abnormal plasma cells multiply uncontrollably . . .
Targeted cancer therapies have changed how cancer is treated by focusing on the molecular and genetic makeup of cancer cells. These therapies differ from chemotherapy, . . .
Relapse in multiple myeloma happens when the disease returns after a period of remission. It may occur months or even years after the initial treatment, and its management . . .
Immunotherapy is a treatment approach that enhances the natural defense mechanisms of the body to identify and fight cancer cells. In the context of blood . . .
Automation allows businesses to optimize their workflows by minimizing repetitive manual processes. It ensures that marketing messages are sent at the right time, to the . . .
Multiple myeloma is a type of blood cancer that originates in plasma cells, a vital component of the immune system responsible for producing antibodies. Over the years, researchers . . .
Learning how lifestyle choices can complement medical care is essential for individuals with Her2 negative breast cancer. While treatment remains the cornerstone of management, adopting supportive habits in . . .
Hormone therapy is a commonly used treatment for Her2 negative breast cancer that is sensitive to estrogen or progesterone. Read this guide to understand how hormone therapy works, . . .
Understanding Supportive Care in Her2 Negative Breast Cancer
Supportive care in Her2 negative breast cancer encompasses various strategies to help patients manage symptoms and maintain health. It . . .
Understanding the treatment options for Her2 negative cancer can be overwhelming. Chemotherapy and hormone therapy are commonly used approaches that help in controlling cancer growth and improving patient . . .